Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples